IRIS
MEROLA, Elettra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.393
AS - Asia 1.847
SA - Sud America 1.560
EU - Europa 474
Continente sconosciuto - Info sul continente non disponibili 131
AF - Africa 84
OC - Oceania 1
Totale 11.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.271
BR - Brasile 1.255
VN - Vietnam 636
SG - Singapore 447
HK - Hong Kong 243
CN - Cina 238
AR - Argentina 142
FR - Francia 95
IT - Italia 88
DE - Germania 60
ID - Indonesia 59
EC - Ecuador 52
BD - Bangladesh 46
MX - Messico 45
RU - Federazione Russa 45
GB - Regno Unito 44
CA - Canada 42
IN - India 41
PY - Paraguay 28
ZA - Sudafrica 27
CO - Colombia 26
IQ - Iraq 25
FI - Finlandia 21
ES - Italia 18
AT - Austria 17
UA - Ucraina 17
VE - Venezuela 15
CL - Cile 14
PK - Pakistan 14
PL - Polonia 13
MA - Marocco 12
NL - Olanda 12
SE - Svezia 12
JP - Giappone 11
PE - Perù 11
TR - Turchia 11
EG - Egitto 10
TN - Tunisia 10
UZ - Uzbekistan 10
KZ - Kazakistan 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
SA - Arabia Saudita 8
DO - Repubblica Dominicana 7
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
OM - Oman 6
ET - Etiopia 5
IL - Israele 5
LT - Lituania 5
AZ - Azerbaigian 4
BB - Barbados 4
DZ - Algeria 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
LB - Libano 3
NI - Nicaragua 3
RO - Romania 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
KW - Kuwait 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
SV - El Salvador 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
MZ - Mozambico 1
PR - Porto Rico 1
QA - Qatar 1
SD - Sudan 1
SN - Senegal 1
TW - Taiwan 1
Totale 11.359
Salva come PNG Salva come JPEG
Città #
Dallas 6.047
Ho Chi Minh City 261
San Jose 259
Hong Kong 238
Ashburn 203
Hanoi 138
Council Bluffs 137
Singapore 107
Columbus 105
São Paulo 97
Beijing 87
Lauterbourg 80
Los Angeles 64
Rio de Janeiro 46
New York 35
Buenos Aires 27
Brasília 25
Haiphong 25
Phoenix 25
Orem 23
Curitiba 21
Chicago 20
Rome 20
Santa Clara 19
Campinas 18
Quito 18
Belo Horizonte 17
Munich 17
Mexico City 16
Da Nang 15
Hải Dương 15
Montreal 15
Buffalo 14
Guayaquil 14
Thái Bình 14
Atlanta 13
Caxias do Sul 13
Johannesburg 13
Warsaw 13
Biên Hòa 12
Fortaleza 12
Guarulhos 12
Naples 12
Ninh Bình 12
Porto Alegre 12
Uberlândia 12
Asunción 11
Düsseldorf 11
Frankfurt am Main 11
Goiânia 11
Helsinki 11
Juiz de Fora 11
Nuremberg 11
Baghdad 10
Bắc Giang 10
Denver 10
Niterói 10
Osasco 10
Stockholm 10
Tokyo 10
Turku 10
Chennai 9
Dhaka 9
Manchester 9
Piracicaba 9
Poplar 9
Ribeirão Preto 9
Salvador 9
San Francisco 9
Vienna 9
Amsterdam 8
Contagem 8
Jakarta 8
Santa Maria 8
Thái Nguyên 8
Americana 7
Boston 7
Can Tho 7
Córdoba 7
Ha Long 7
Houston 7
Ipatinga 7
Lima 7
London 7
Manaus 7
Marília 7
Montevideo 7
Passo Fundo 7
São Bernardo do Campo 7
São José 7
Tashkent 7
Trento 7
Alvorada 6
Amman 6
Cape Town 6
Ciudad del Este 6
Cotia 6
Duque de Caxias 6
Londrina 6
Maceió 6
Totale 8.863
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations 586
HETEROGENEITY OF TYPE 1 GASTRIC NEUROENDOCRINE NEOPLASMS 354
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 352
Reassessment of Proliferative Activity at Disease Progression in Neuroendocrine Neoplasms 348
Curative Resection in Digestive Neuroendocrine Neoplasms: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 346
FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs) 340
Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms 335
Contrast Enhanced Ultrasonography (CEUS) and Quantitative Perfusion Analysis in the Assessment of Neuroendocrine Liver Metastases 334
Peritoneal Carcinomatosis in Digestive Neuroendocrine Neoplasms: Complications and Response to Therapy 333
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors 331
Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 329
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers 327
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 326
Role of Somatostatin Receptors scintigraphy in neuroendocrine neoplasms follow-up 323
REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS 319
Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients 312
Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients 310
Histopathological Revision forGastroenteropancreatic NeuroendocrineNeoplasms in Expert Centers: Does It Make theDifference? 302
Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 298
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 260
Curative resection in digestive neuroendocrine neoplasms: Recurrence-free survival rate and definition of a risk score for recurrence 259
- Lineeguida AIOM-ITANET “Neoplasie Neuroendocrine gastroenteropancreatiche”; edizione 2015 187
Artificial Intelligence for Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 130
P53 and the malignant progression of Barrett's esophagus 103
ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors 94
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 93
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms 90
Appendiceal collision tumors: case reports, management and literature review 90
Cap-assisted EMR for large colorectal laterally spreading tumors: a cautionary tale from real-life experience 89
Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting 89
Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker? 85
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis 84
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 79
Cap-assisted endoscopic mucosal resection as a salvage technique for challenging colorectal laterally spreading tumors 79
Commentary: Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis 79
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 75
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome 74
Portosystemic encephalopathy in an 86-year-old patient : a clinical challenge 72
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres 71
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications 70
Neuroendocrine tumors 70
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 69
Nasogastric or nasointestinal feeding in severe acute pancreatitis 67
Role of impaired epithelial barrier of esophageal body and of proximal reflux in the pathophysiology of non-erosive gastroesophageal reflux disease 67
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 66
Prevalence of gastrointestinal symptoms in coronavirus disease 2019: a meta-analysis 65
Device-assisted enteroscopy: Are we ready to dismiss the spiral? 64
Two-devices-in-one-channel technique for precut sphincterotomy 64
Pre-Endoscopy real-time PCR testing for SARS-CoV2 does not reduce health care workers infection and is associated with a higher reduction of endoscopic activity in an outpatient setting 64
Functional Imaging Tests versus Computed Tomography Scan: Detection of New Metastases and Clinical Usefulness in Digestive Neuroendocrine Neoplasms Follow-Up 63
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome 63
Efficacy and Toxicity of 5-Fluorouracil-Oxaliplatin in Gastroenteropancreatic Neuroendocrine Neoplasms 63
Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives 63
Prevalence of liver injury in patients with coronavirus disease 2019 (COVID-19) : a systematic review and meta-analysis 63
ENDOSCOPIC DIAGNOSIS OF NEUROENDOCRINE NEOPLASMS: A REAL-WORLD EXPERIENCE 61
Role of ACE1, ACE2, and CCR5-Δ32 Polymorphisms in the Transmission of SARS-CoV-2 to Intimate Contacts 61
TYPE I GASTRIC CARCINOIDS: A PROSPECTIVE STUDY ON ENDOSCOPICMANAGEMENT AND RECURRENCE RATE 61
Sequential Therapies in Well-Differentiated Gastrointestinal Neuroendocrine Tumors G3 (NET G3): Platinum-Based vs. Platinum-Free Regimens 60
Hepatitis C virus burden: Treating and educating people without prejudice 60
Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements 60
DIAGNOSTICS OF HEREDITARY COLORECTAL CANCER SYNDROMES: A REAL-WORLD EXPERIENCE 59
High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent 58
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21 waf-1, p27, and PCNA in Barrett's esophagus 57
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 56
Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective 56
Treatment of Pancreatic Neuroendocrine Tumors 56
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) 55
Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options 55
Role of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding 54
Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? 54
Molecular Pathology of Pancreatic Endocrine Tumors 53
Probiotics and severe acute pancreatitis 53
Optimal timing of endoscopy for acute upper gastrointestinal bleeding: a systematic review and meta-analysis 51
Digestive neuroendocrine neoplasms: A 2016 overview 51
Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature 51
Probiotics and severe acute pancreatitis. Addendum 49
Advances and future perspectives in the pharmacological treatment of Helicobacter pylori infection: Taking advantage from artificial intelligence 48
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 48
Recurrence rates after piecemeal endoscopic mucosal resection of large colorectal laterally spreading tumors 46
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? 43
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms 43
PuraStat for gastrointestinal bleeding management: Effective approach for endoscopic prevention and rescue therapy 41
Bone metastases from neuroendocrine neoplasms: Resultsof an Italian nationwide survey of natural historyand management 33
Glucose-6-Phosphate Dehydrogenase Deficiency and Cardiovascular Risk in Familial Hypercholesterolemia: A Retrospective Cohort Study 32
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected Adults 31
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 30
P0377 Dual-Energy and Photon-Counting Computed Tomography in Crohn’s Disease: Towards Quantitative Imaging Biomarkers. A Systematic Review 27
Educational Materials for Helicobacter pylori Infection: A Comparative Evaluation of Large Language Models Versus Human Experts 24
High-grade gastro-entero-pancreatic neuroendocrine neoplasms: An overlooked population in interventional clinical trials. A systematic review 23
Helicobacter pylori and Cancer: What’s the Link? 21
Comment on: "Man Plus Machine: A Randomized Control Trial of Artificial Intelligence Including the Impact of Adjunctive Polyp Detection Techniques" 19
Predicting the Unpredictable: AI-Driven Prognosis in Pancreatic Neuroendocrine Neoplasms 18
Pancreatic Injuries: What Should Trauma Radiologists Know in 2026? 18
Artificial Intelligence as a Safeguard for Clinical Scientific Integrity: A Human–AI Hybrid Model for Medical Peer Review 9
Rectal mixed adenoma-neuroendocrine lesion: a rare case report 8
Persistence of the APOE ε4 Allele Among Sardinian Nonagenarians: Longitudinal Survival Evidence from a Blue Zone Cohort 7
General anesthesia with intubation and emergency endoscopy outcomes in patients with upper gastrointestinal bleeding: an inverse probability of treatment weighting study 7
Helicobacter pylori infection and neurological disorders: association, mechanisms, and clinical implications 5
Interventional Clinical Trials in Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Systematic Review of Prospective, Interventional Trials 5
The missing evidence: Stricturing Crohn's disease in clinical trials, a systematic review 5
Totale 11.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.059
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025944 0 0 0 0 0 0 0 0 0 749 97 98
2025/202610.136 325 3.316 3.510 1.584 245 219 303 147 164 167 127 29
2026/2027410 117 293 0 0 0 0 0 0 0 0 0 0
Totale 11.490